CIBC Bancorp USA’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.23M Sell
60,775
-9,671
-14% -$848K 0.01% 733
2026
Q1
$6.37M Buy
+70,446
New +$6.46M 0.01% 636
2025
Q3
$2.69M Buy
+27,321
New +$2.71M 0.01% 539

Other funds holding ZBH

CIBC Bancorp USA's ZBH Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Zimmer Biomet (ZBH) stake by 14% in Q2 2026, selling an estimated $848K and leaving 60,775 shares worth $5.23M. The position accounts for 0.01% of the portfolio, ranked #733.

CIBC Bancorp USA first reported a position in ZBH in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.37M in Q1 2026. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • CIBC Bancorp USA held 60,775 shares of Zimmer Biomet worth $5.23M as of Q2 2026.
  • CIBC Bancorp USA sold 9,671 Zimmer Biomet shares in Q2 2026, an estimated $848K.
  • Zimmer Biomet made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #733 holding.
  • CIBC Bancorp USA first reported a position in Zimmer Biomet in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Zimmer Biomet position peaked at $6.37M in Q1 2026.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.